Drugs / oral betamethasone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02586961 | Oct 2015 → Sep 2017 | acute bronchiolitis | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oral betamethasone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02586961 ↗ |
| Modality | Small molecule | “Mineralocorticoid: a short course of oral betamethasone: 1.0 mg/kg at inclusion, followed by five once-daily doses (0.6 mg/kg)” NCT02586961 ↗ |
| Route | Oral | “Mineralocorticoid: a short course of oral betamethasone: 1.0 mg/kg at inclusion, followed by five once-daily doses (0.6 mg/kg)” NCT02586961 ↗ |